Literature DB >> 25027943

Avoiding and identifying errors and other threats to the credibility of health economic models.

Paul Tappenden1, James B Chilcott.   

Abstract

Health economic models have become the primary vehicle for undertaking economic evaluation and are used in various healthcare jurisdictions across the world to inform decisions about the use of new and existing health technologies. Models are required because a single source of evidence, such as a randomised controlled trial, is rarely sufficient to provide all relevant information about the expected costs and health consequences of all competing decision alternatives. Whilst models are used to synthesise all relevant evidence, they also contain assumptions, abstractions and simplifications. By their very nature, all models are therefore 'wrong'. As such, the interpretation of estimates of the cost effectiveness of health technologies requires careful judgements about the degree of confidence that can be placed in the models from which they are drawn. The presence of a single error or inappropriate judgement within a model may lead to inappropriate decisions, an inefficient allocation of healthcare resources and ultimately suboptimal outcomes for patients. This paper sets out a taxonomy of threats to the credibility of health economic models. The taxonomy segregates threats to model credibility into three broad categories: (i) unequivocal errors, (ii) violations, and (iii) matters of judgement; and maps these across the main elements of the model development process. These three categories are defined according to the existence of criteria for judging correctness, the degree of force with which such criteria can be applied, and the means by which these credibility threats can be handled. A range of suggested processes and techniques for avoiding and identifying these threats is put forward with the intention of prospectively improving the credibility of models.

Entities:  

Mesh:

Year:  2014        PMID: 25027943     DOI: 10.1007/s40273-014-0186-2

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  20 in total

1.  The sixth stool guaiac test: $47 million that never was.

Authors:  K Brown; C Burrows
Journal:  J Health Econ       Date:  1990       Impact factor: 3.883

Review 2.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

3.  What do we gain from the sixth stool guaiac?

Authors:  D Neuhauser; A M Lewicki
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

Review 4.  Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Authors:  Z Philips; L Ginnelly; M Sculpher; K Claxton; S Golder; R Riemsma; N Woolacoot; J Glanville
Journal:  Health Technol Assess       Date:  2004-09       Impact factor: 4.014

5.  Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison.

Authors:  Corinna Sorenson
Journal:  Issue Brief (Commonw Fund)       Date:  2010-07

6.  Modelling in economic evaluation: an unavoidable fact of life.

Authors:  M J Buxton; M F Drummond; B A Van Hout; R L Prince; T A Sheldon; T Szucs; M Vray
Journal:  Health Econ       Date:  1997 May-Jun       Impact factor: 3.046

7.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  Value Health       Date:  2013 Mar-Apr       Impact factor: 5.725

8.  The "hazards" of extrapolating survival curves.

Authors:  Charlotte Davies; Andrew Briggs; Paula Lorgelly; Göran Garellick; Henrik Malchau
Journal:  Med Decis Making       Date:  2013-03-03       Impact factor: 2.583

9.  Toward a peer review process for medical decision analysis models.

Authors:  F A Sonnenberg; M S Roberts; J Tsevat; J B Wong; M Barry; D L Kent
Journal:  Med Care       Date:  1994-07       Impact factor: 2.983

10.  Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.

Authors:  David M Eddy; William Hollingworth; J Jaime Caro; Joel Tsevat; Kathryn M McDonald; John B Wong
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

View more
  8 in total

1.  Replicating Health Economic Models: Firm Foundations or a House of Cards?

Authors:  Inigo Bermejo; Paul Tappenden; Ji-Hee Youn
Journal:  Pharmacoeconomics       Date:  2017-11       Impact factor: 4.981

Review 2.  Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.

Authors:  Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

Review 3.  Model Structuring for Economic Evaluations of New Health Technologies.

Authors:  Hossein Haji Ali Afzali; Laura Bojke; Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2018-11       Impact factor: 4.981

4.  Four Aspects Affecting Health Economic Decision Models and Their Validation.

Authors:  Talitha Feenstra; Isaac Corro-Ramos; Dominique Hamerlijnck; George van Voorn; Salah Ghabri
Journal:  Pharmacoeconomics       Date:  2021-12-16       Impact factor: 4.981

Review 5.  Appraisal of patient-level health economic models of severe mental illness: systematic review.

Authors:  James Altunkaya; Jung-Seok Lee; Apostolos Tsiachristas; Felicity Waite; Daniel Freeman; José Leal
Journal:  Br J Psychiatry       Date:  2021-08-19       Impact factor: 9.319

6.  Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.

Authors:  Miriam Brazzelli; Lorna Aucott; Magaly Aceves-Martins; Clare Robertson; Elisabet Jacobsen; Mari Imamura; Amudha Poobalan; Paul Manson; Graham Scotland; Callum Kaye; Simon Sawhney; Dwayne Boyers
Journal:  Health Technol Assess       Date:  2022-01       Impact factor: 4.106

7.  Implementing parallel spreadsheet models for health policy decisions: The impact of unintentional errors on model projections.

Authors:  Stephanie L Bailey; Rose S Bono; Denis Nash; April D Kimmel
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

8.  TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility.

Authors:  Nasuh C Büyükkaramikli; Maureen P M H Rutten-van Mölken; Johan L Severens; Maiwenn Al
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.